choroiditis

(redirected from posterior uveitis)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to posterior uveitis: anterior uveitis

choroiditis

(ˌkɔːrɔɪdˈaɪtɪs)
n
a medical condition consisting of pain and swelling of the choroid
Translations

cho·roid·i·tis

n. coroiditis, infl. de la coroides.
References in periodicals archive ?
The Company is developing EYS606, an innovative combination product associating a DNA plasmid encoding a therapeutic protein with an injection-electroporation device, for the treatment of Non-Infectious Posterior Uveitis (NIU).
plans to file a New Drug Application (NDA) for Medidur for posterior uveitis based on six-month efficacy data for both Phase III trials.
Toxoplasmosis is the most common cause of posterior uveitis.
Anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis are the common types of uveitis; among these, anterior uveitis is the most common type of uveitis.
This report provides comprehensive information on the therapeutic development for Posterior Uveitis.
Patients who had vitritis with retinitis and/or vasculitis were classified as having posterior uveitis, and those who had anterior and posterior uveitis at the same time were classified as having panuveitis.
A recent international expert panel suggested that anti-TNF therapy might be suitable for patients with severe, organ-threatening disease--patients with two or more relapses of posterior uveitis per year--low visual acuity resulting from chronic cystoid macular edema, or active central nervous system disease (Rheumatology 2007;46:736-41).
Originally thought of as two separate entities, Vogt-Koyanagi disease (with severe anterior uveitis, frequent vitiligo, and poliosis) and Harada's disease (with bilateral severe posterior uveitis, exudative retinal detachment, and slight anterior uveitis), these disorders are now thought to be a spectrum of one disease because they share clinical characteristics.
We are pleased with the progress of our lead development product, an injectable micro-insert for posterior uveitis.
pSivida's lead product candidate, Medidur for the treatment of posterior uveitis, is currently in pivotal phase III clinical trials.
pSivida's FDA-approved Retisert, licensed to Bausch & Lomb Incorporated, provides long-term, sustained drug delivery to treat posterior uveitis.
Infliksimab in the treatment of refractory posterior uveitis.
Full browser ?